Temodal, a crucial medication for treating certain types of brain tumors, is manufactured by Merck & Co.
Understanding Temodal and Its Manufacturer
Temodal is the brand name for the active pharmaceutical ingredient temozolomide. This medication is an alkylating agent primarily used in chemotherapy for various types of brain cancer, including newly diagnosed glioblastoma multiforme and refractory anaplastic astrocytoma.
Merck & Co., known as MSD outside of the United States and Canada, is one of the largest and most prominent pharmaceutical companies globally. They are responsible for the comprehensive lifecycle of Temodal, encompassing its research, development, manufacturing, and worldwide distribution. Their significant contributions to oncology have resulted in the creation of several vital cancer treatments, with temozolomide being a notable example in their portfolio.
Key Product Information
To summarize the essential details about Temodal and its origin:
| Aspect | Detail |
|---|---|
| Manufacturer | Merck & Co. (also known as MSD) |
| Brand Name | Temodal |
| Active Ingredient | Temozolomide |
| Therapeutic Class | Alkylating Agent (Chemotherapy) |
| Primary Use | Treatment of specific brain tumors |
Merck & Co.'s role ensures the quality and global availability of Temodal for patients, contributing significantly to the management of challenging oncological conditions.
You can learn more about Merck & Co. on their official website: Merck.com.
